Clinical Trial Update: Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration

View source ↗

Summary

Pfizer-sponsored observational study evaluates long-term effects of Macugen (pegaptanib) in patients with wet age-related macular degeneration; results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Macular Degeneration

Drugs mentioned

• Macugen (pegaptanib sodium)

Snippet

Sponsor: Pfizer | Conditions: Macular Degeneration, Age-related Macular Degeneration | Status: COMPLETED | Results posted: 2011-01-07